These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Separation, identification, and quantitation of anthralin and its decomposition products. Elsabbagh HM; Whitworth CW; Schramm LC J Pharm Sci; 1979 Mar; 68(3):388-90. PubMed ID: 423140 [TBL] [Abstract][Full Text] [Related]
6. Application of polarography to the development of a stability-indicating assay method for a new indole derivative and its tablet formulations. Chan HK J Pharm Pharmacol; 1974 Dec; 26 Suppl():37P-40P. PubMed ID: 4156732 [No Abstract] [Full Text] [Related]
7. Stability of parenteral solutions of cefazolin sodium. Bornstein M; Thomas PN; Coleman DL; Boylan JC Am J Hosp Pharm; 1974 Mar; 31(3):296-8. PubMed ID: 4206616 [No Abstract] [Full Text] [Related]
9. The stability of aqueous solutions of phenylephrine at elevated temperatures: identification of the decomposition products. Millard BJ; Priaulx DJ; Shotton E J Pharm Pharmacol; 1973 Dec; 25():Suppl:24P-31P. PubMed ID: 4150588 [No Abstract] [Full Text] [Related]
10. [Analysis and stability of suxamethonium chloride. 1. Detection and quantitative determination of the intact active agent with its degradation products]. Döge G; Pohloudek-Fabini R; Kottke D Pharmazie; 1982 Oct; 37(10):708-11. PubMed ID: 7178216 [TBL] [Abstract][Full Text] [Related]
11. Kinetics of Craviten decomposition in aqueous solutions. Kubiak Z; Kuncewicz B; Zurańska M Pol J Pharmacol Pharm; 1980; 32(6):917-25. PubMed ID: 7243688 [TBL] [Abstract][Full Text] [Related]
12. [The stability of bromhexine and the structure of its degradation products]. Göber B; Lisowski H; Franke P Pharmazie; 1988 Jan; 43(1):23-6. PubMed ID: 3375295 [TBL] [Abstract][Full Text] [Related]
13. A stability-indicating assay and the preformulation characteristics of the radiosensitizer, 1,2,4-benzotriazin-3-amine 1,4-dioxide. Riley CM; Shetty BV; Chetwyn NC; Kasper VT; Kindberg CG; Dicken CM J Pharm Biomed Anal; 1993 Feb; 11(2):131-8. PubMed ID: 8504184 [TBL] [Abstract][Full Text] [Related]
14. Thin-layer chromatographic analysis of fludarabine and formycin A in human plasma. Paw B; Misztal G; Dzwonnik K Acta Pol Pharm; 2000; 57(5):341-3. PubMed ID: 11126023 [TBL] [Abstract][Full Text] [Related]
15. [Azidomorphine stability in solutions. I. Analytic methods for the control of disintegration]. Gyarmati L; Rácz I; Plachy J; Mezei J Acta Pharm Hung; 1978 Nov; 48(6):267-74. PubMed ID: 716934 [No Abstract] [Full Text] [Related]
17. Chemical characterization of decomposition products of pyrazolidinedione-3,5 derivatives. Part 1: Identification of decomposition products and mechanism of degradation of 4-prenyl-1,2-diphenyl-3,5-pyrazolidine-dione in an aqueous solution. Wachowiak R Arzneimittelforschung; 1979; 29(4):599-602. PubMed ID: 582752 [TBL] [Abstract][Full Text] [Related]
18. The difference spectrophotometric assay of 5-hydroxymethylfurfuraldehyde in parenteral formulations of dextrose. Davidson AG J Clin Pharm Ther; 1987 Feb; 12(1):11-8. PubMed ID: 3449559 [TBL] [Abstract][Full Text] [Related]
19. [Analytical methods for stability testing of metronidazole infusion solutions]. Ebel S; Ledermann M; Mümmler B Arch Pharm (Weinheim); 1990 Apr; 323(4):195-200. PubMed ID: 2360862 [TBL] [Abstract][Full Text] [Related]